All Episodes

September 30, 2025 1 min

by Nicolas Hulscher, MPH

Today, Pfizer announced a landmark agreement with the Trump Administration. The press release promised lower drug costs and a revival of U.S. manufacturing. President Donald Trump touted that Pfizer would cut Medicaid drug prices for low-income Americans and sell new medicines at a “most-favored-nation” price — but only in exchange for tariff relief.

In reality, it appears to be a multi-billion dollar effort to entrench Pfizer’s failed gene-transfer platforms for decades to come.

The deal secures a $70 billion commitment to U.S. R&D — a down payment on Pfizer’s next wave of gene-based products:

* Cancer “vaccines”

* Obesity injections

* Expanded vaccine portfolio (flu, RSV, bird flu, more)

* Chronic disease biologics in inflammation & immunology

Pfizer itself spelled it out:

“With this agreement in place, Pfizer can fully focus on delivering the next generation of cures… in areas like oncology, obesity, vaccines, and inflammation and immunology.”

This comes after Pfizer’s COVID-19 gene-based products have already been linked to catastrophic injuries, deaths, and disabilities worldwide. Instead of scrutiny, the company is rewarded with protection and growth.

CEO Albert Bourla called the deal a “win for patients, a win for leadership, and a win for Pfizer.” He’s right about the last part.

By pledging billions in “investment,” Pfizer secured tariff relief, regulatory stability, and political cover to expand its mRNA pipeline — despite the obvious trail of death and destruction its previous and current products left behind.

The message is clear: accountability is off the table, and Pfizer’s genetic empire now stands shielded by the U.S. government itself.

Nicolas Hulscher, MPH

Epidemiologist and Foundation Administrator, McCullough Foundation

Support our mission: mcculloughfnd.org

Please consider following both the McCullough Foundation and my personal account on X (formerly Twitter) for further content.

FOCAL POINTS (Courageous Discourse) is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.thefocalpoints.com/subscribe
Mark as Played

Advertise With Us

Popular Podcasts

Stuff You Should Know
Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

Cardiac Cowboys

Cardiac Cowboys

The heart was always off-limits to surgeons. Cutting into it spelled instant death for the patient. That is, until a ragtag group of doctors scattered across the Midwest and Texas decided to throw out the rule book. Working in makeshift laboratories and home garages, using medical devices made from scavenged machine parts and beer tubes, these men and women invented the field of open heart surgery. Odds are, someone you know is alive because of them. So why has history left them behind? Presented by Chris Pine, CARDIAC COWBOYS tells the gripping true story behind the birth of heart surgery, and the young, Greatest Generation doctors who made it happen. For years, they competed and feuded, racing to be the first, the best, and the most prolific. Some appeared on the cover of Time Magazine, operated on kings and advised presidents. Others ended up disgraced, penniless, and convicted of felonies. Together, they ignited a revolution in medicine, and changed the world.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.